Literature DB >> 10748867

Abl expression, tumour grade, and apoptosis in chondrosarcoma.

M O'Donovan1, J M Russell, J J O'Leary, J A Gillan, M P Lawler, E F Gaffney.   

Abstract

AIMS: To determine whether Abl immunoreactivity correlates with grade and cell kinetics (apoptosis and mitosis) in chondrosarcoma.
METHODS: Sections from 16 chondrosarcomas were stained immunohistochemically using a polyclonal antibody to the c-Abl/Bcr-Abl oncoprotein. Apoptotic indices and mitotic indices were assessed in all tumours. Sections from 24 paraffin wax blocks of human fetal rib (gestational ages, 15-42 weeks) were also stained to determine whether the Abl protein is synthesised consistently throughout endochondral ossification.
RESULTS: Abl staining in immature fetal rib chondrocytes at all stages of development was predominantly nuclear, and 70% of cells showed moderate to strong staining. Abl immunoreactivity was minimal or absent in hypertrophic chondrocytes about to undergo apoptosis at the growth plate. There was strong Abl staining in grade 1 and grade 2 chondrosarcomas but staining was greatly reduced or absent in grade 3 chondrosarcomas. There was a very significant linear correlation between apoptotic index (mean, 0.68%; range, 0-3.2%) and mitotic index (mean, 0.23%; range, 0-0.9%), and both indices were significantly lower in grade 1 than in grade 2 and grade 3 chondrosarcomas.
CONCLUSIONS: These data suggest that abl gene expression is associated with differentiation and apoptosis inhibition in fetal and neoplastic chondrocytes. However, these putative effects cannot be ascribed solely to the Abl protein, because several additional factors contribute to the regulation of both differentiation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10748867      PMCID: PMC395719          DOI: 10.1136/mp.52.6.341

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  28 in total

1.  Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma.

Authors:  A J O'Neill; M J Staunton; E F Gaffney
Journal:  Histopathology       Date:  1996-07       Impact factor: 5.087

2.  Apoptosis of terminally differentiated chondrocytes in culture.

Authors:  G Gibson; D L Lin; M Roque
Journal:  Exp Cell Res       Date:  1997-06-15       Impact factor: 3.905

Review 3.  The ABL genes in normal and abnormal cell development.

Authors:  S W Chung; R Daniel; B Y Wong; P M Wong
Journal:  Crit Rev Oncog       Date:  1996

4.  The abl oncogene family and apoptosis.

Authors:  A J McGahon; T G Cotter; D R Green
Journal:  Cell Death Differ       Date:  1994       Impact factor: 15.828

5.  HHV8 and female Kaposi's sarcoma.

Authors:  M M Kennedy; S B Lucas; R Russell-Jones; D D Howells; S J Picton; A Bardon; I L Comley; J O McGee; J J O'Leary
Journal:  J Pathol       Date:  1997-12       Impact factor: 7.996

6.  Tumor type is a determinant of susceptibility to apoptosis.

Authors:  M J Staunton; E F Gaffney
Journal:  Am J Clin Pathol       Date:  1995-03       Impact factor: 2.493

Review 7.  A matter of life and cell death.

Authors:  G Evan; T Littlewood
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

8.  Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.

Authors:  P K Lipponen; S Aaltomaa
Journal:  J Pathol       Date:  1994-08       Impact factor: 7.996

Review 9.  Apoptosis: basic concepts and potential significance in human cancer.

Authors:  M J Staunton; E F Gaffney
Journal:  Arch Pathol Lab Med       Date:  1998-04       Impact factor: 5.534

10.  Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes.

Authors:  M Enomoto-Iwamoto; M Iwamoto; Y Mukudai; Y Kawakami; T Nohno; Y Higuchi; S Takemoto; H Ohuchi; S Noji; K Kurisu
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

View more
  6 in total

1.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

2.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

3.  Chondrosarcoma cell differentiation.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

4.  c-Abl Kinase Is a Regulator of αvβ3 Integrin Mediated Melanoma A375 Cell Migration.

Authors:  Chunmei Zhang; Chao Yang; Ruifei Wang; Yang Jiao; Khamal Kwesi Ampah; Xiaoguang Wang; Xianlu Zeng
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

5.  rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.

Authors:  Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Sarah Schetting; Myriam Ekici; Dieter Kohn; Magali Cucchiarini
Journal:  Sarcoma       Date:  2012-05-07

Review 6.  Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies.

Authors:  Fiona H Tan; Tracy L Putoczki; Stanley S Stylli; Rodney B Luwor
Journal:  Onco Targets Ther       Date:  2019-01-18       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.